High-grade dysplasia in Barrett's esophagus: The case for esophagectomy

Chest Surgery Clinics of North America

Volumn 12, Issue 1, 2002, Pages 77-92

  Collard, Jean Marie ^a,b  

^a Louvain Medical School   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER INVASION; CANCER STAGING; DIAGNOSTIC ACCURACY; ESOPHAGUS DISEASE; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; GASTROINTESTINAL ENDOSCOPY; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036190680     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(03)00067-X     Document Type: Review

References (84)

1. Esophageal stripping with preservation of the vagus nerve
2. High-grade dysplasia in the columnar-lined esophagus
3. Impact of hospital volume on operative mortality for major cancer surgery
4. Reconstruction of the esophagus with left colon
5. Motor activity after colon replacement of esophagus
6. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
7. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study
8. Complications of Barrett's esophagus: Indications for esophageal resection with special reference to high-grade dysplasia
9. A single centre′s 20 years′ experience of columnar-lined (Barrett's) oesophagus diagnosis
10. Peptic stenosis: What are the residual indications of esophagectomy in reference to the other therapies?
11. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus
12. Exclusive radical surgery for esophageal adenocarcinoma
13. Skeletonizing en-bloc esophagectomy for cancer
14. An original technique for lengthening the stomach as an oesophageal substitute after esophagectomy. Preliminary results
15. Esophageal replacement: Gastric tube or whole stomach?
16. Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy
17. The denervated stomach as an esophageal substitute is a contractile organ
18. Human stomach has a recordable mechanical activity at a rate of about three cycles/minute
19. Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute
20. Roux-en-Y jejunal loop and bile reflux
21. Indications, surgical techniques, and long-term functional results of colon interposition
22. Barrett esophagus in the esophageal stump after subtotal esophagectomy with cervical esophago-gastroplasty
23. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction
24. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia
25. Endoscopic mucosal resection of early cancer and highgrade dysplasia in Barrett's esophagus
26. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia
27. Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia
28. Resection for Barrett's mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy
29. Is it possible to make the unequivocal diagnosis of dysplasia, especially low-grade dysplasia in Barrett's mucosa?
30. Is the natural history of high-grade dysplasia known?
31. Bile exposure of the denervated stomach as an esophageal substitute
32. Denervated stomach as an esophageal substitute recovers intraluminal acidity with time
33. Barrett's esophagus: Development of dysplasia and adenocarcinoma
34. The relationship between columnar epithelial dysplasia and invasive carcinoma arising in Barrett's esophagus
35. Regeneration of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy
36. Barrett's esophagus with high-grade dysplasia: An indication for prophylactic esophagectomy
37. The increasing frequency of adenocarcinoma of the esophagus
38. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma
39. Gastric juice protects against the development of esophageal adenocarcinoma in the rat
40. Functional and mechanical sequelae of colon interposition for benign disease
41. Outcome 5 years after 360 degree fundoplication for gastroesophageal reflux disease
42. The epidemiology of esophageal carcinoma. The changing face of a disease
43. Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients
44. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis
45. Natural history of high-grade dysplasia in Barrett's esophagus
46. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
47. Cervical Barrett's esophagus. A common complication of gastric tube reconstruction
48. Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus
49. Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance?
50. The jejunal interposition operation for substitution of the esophagogastric sphincter
51. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia
52. Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy
53. Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study
54. Les plasties coliques de l'œsophage
55. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
56. Management of high-grade dysplasia in Barrett's esophagus
57. Erythromycin is a motilin-receptor agonist
58. Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?
59. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
60. Colonic interposition for esophageal substitution
61. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions
62. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
63. Surgical management of high-grade dysplasia in Barrett's esophagus
64. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus
65. Are proton pump inhibitors alone able to induce regression in the length of Barrett's esophagus?
66. Dysplasia in Barrett's esophagus
67. Electrophysiological identification of vagally innervated enteric neurons in Guinea pig stomach
68. Barrett's esophagus: Comparison of benign and malignant cases
69. Surveillance for Barrett's oesophagus in the UK
70. Surgical anatomy of the arterial supply to the colon from the superior mesenteric artery based upon a study of 600 specimens
71. Limited resection for early adenocarcinoma in Barrett's esophagus
72. Endoscopic surveillance of Barrett's esophagus: Does it help?
73. Changing patterns and surgical results in adenocarcinoma of the oesophagus
74. A long-term randomized prospective trial of Nissen procedure versus a modified Toupet technique
75. Complete eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid-term results
76. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus
77. Surveillance of Barrett's oesophagus: Physicians' practices and review of current guidelines
78. Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility
79. Is the increasing use of drug therapy for reflux esophagus a possible cause of sustained mitotic stimulation, eventually promoting esophageal carcinogenesis?
80. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus